1. Home
  2. EH vs FTRE Comparison

EH vs FTRE Comparison

Compare EH & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EHang Holdings Limited ADS

EH

EHang Holdings Limited ADS

HOLD

Current Price

$9.88

Market Cap

745.8M

Sector

Industrials

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$10.66

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EH
FTRE
Founded
2014
1996
Country
China
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
745.8M
829.3M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
EH
FTRE
Price
$9.88
$10.66
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$22.47
$14.06
AVG Volume (30 Days)
505.1K
946.1K
Earning Date
05-26-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$33.23
N/A
Revenue Next Year
$73.83
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$9.06
$3.97
52 Week High
$20.44
$18.67

Technical Indicators

Market Signals
Indicator
EH
FTRE
Relative Strength Index (RSI) 38.27 57.98
Support Level $9.06 $8.80
Resistance Level $11.94 $11.59
Average True Range (ATR) 0.41 0.61
MACD -0.09 0.13
Stochastic Oscillator 4.41 83.70

Price Performance

Historical Comparison
EH
FTRE

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: